Skip to main content
. 2015 Mar 16;8:641–648. doi: 10.2147/OTT.S80913

Figure 1.

Figure 1

Association of the ERCC1 rs11615 polymorphism with response to oxaliplatin-based chemotherapy.

Note: Weights are from random-effects analysis.

Abbreviations: ERCC1, excision repair cross-complementing 1; HR, hazard ratio; CI, confidence interval.